PCN5- DOCETAXEL/DOXORRUBICIN (DD) AS FIRST LINE CHEMOTHERAPY- QUALITY OF LIFE (QOL) IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC)
Sep 1, 2001, 00:00 AM
10.1046/j.1524-4733.2001.40202-51.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71210-4/fulltext
Section Title :
Section Order :
102
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71210-4&doi=10.1046/j.1524-4733.2001.40202-51.x